AKR1C3 and prostate carcinoma: AKR1C3, which is also involved in arachidonic acid metabolism, plays a role in the progression of prostate cancer and its resistance to hormone therapy (Adeniji et al., 2013; Chen et al., 2015; Powell et al., 2015).